tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

COYA Stock Latest News

Coya: Low-Dose IL-2 in AD patients resulted in reduced proinflammatory markers
The FlyCoya: Low-Dose IL-2 in AD patients resulted in reduced proinflammatory markers
26d ago
COYA
Coya Therapeutics expands investigational pipeline, advancement of COYA 303
PremiumThe Fly
Coya Therapeutics expands investigational pipeline, advancement of COYA 303
1M ago
COYA
Coya Therapeutics provides enrollment update of COYA 302 study
PremiumThe Fly
Coya Therapeutics provides enrollment update of COYA 302 study
3M ago
COYA
Coya Therapeutics initiated with a Buy at D. Boral Capital
PremiumThe Fly
Coya Therapeutics initiated with a Buy at D. Boral Capital
3M ago
COYA
Coya Therapeutics files to sell 1.38M shares of common stock for holders
PremiumThe Fly
Coya Therapeutics files to sell 1.38M shares of common stock for holders
3M ago
COYA
Coya: COYA 301 – GLP-1 agonists combo synergistic in inflamation amelioration
PremiumThe FlyCoya: COYA 301 – GLP-1 agonists combo synergistic in inflamation amelioration
4M ago
COYA
Coya Therapeutics Reports Q3 2024 Highlights and Progress
Premium
Company Announcements
Coya Therapeutics Reports Q3 2024 Highlights and Progress
4M ago
COYA
Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases
Premium
Company Announcements
Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases
4M ago
8K
COYA
Coya Therapeutics reports Q3 EPS (26c), consensus (41c)
PremiumThe Fly
Coya Therapeutics reports Q3 EPS (26c), consensus (41c)
4M ago
COYA
Coya Therapeutics Announces Leadership Change and New CEO
PremiumCompany Announcements
Coya Therapeutics Announces Leadership Change and New CEO
4M ago
8K
COYA
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results
PremiumCompany Announcements
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results
4M ago
8K
COYA
Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints
PremiumThe Fly
Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints
4M ago
COYA
Coya Therapeutics Announces $10M Private Placement to Advance Pipeline
PremiumCompany AnnouncementsCoya Therapeutics Announces $10M Private Placement to Advance Pipeline
4M ago
8K
COYA
Coya Therapeutics to sell 1.379M shares at $7.25 in private placement
Premium
The Fly
Coya Therapeutics to sell 1.379M shares at $7.25 in private placement
4M ago
COYA
Coya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
Premium
The Fly
Coya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
6M ago
COYA
Coya Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Coya Therapeutics initiated with a Buy at H.C. Wainwright
6M ago
COYA
Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
PremiumThe Fly
Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
7M ago
COYA
Coya Therapeutics reports Q2 EPS (19c), consensus (31c)
PremiumThe Fly
Coya Therapeutics reports Q2 EPS (19c), consensus (31c)
7M ago
COYA
Coya files U.S patents for COYA 301 + GLP-1 receptor agonists
PremiumThe Fly
Coya files U.S patents for COYA 301 + GLP-1 receptor agonists
7M ago
COYA
Coya Therapeutics expands sponsored research collaboration with HMRI
PremiumThe FlyCoya Therapeutics expands sponsored research collaboration with HMRI
9M ago
COYA
Coya Therapeutics files to sell 603,136 shares of common stock for holders
Premium
The Fly
Coya Therapeutics files to sell 603,136 shares of common stock for holders
9M ago
COYA
Coya Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Coya Therapeutics initiated with a Buy at Rodman & Renshaw
9M ago
COYA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >